Prior Authorization Software in Oncology: Improving Patients’ Access to Vital Treatments
The American Cancer Society expects newly diagnosed cancer cases in 2023 to exceed 1.9 million—and that figure doesn’t even factor in skin cancers not subject to reporting. The good news: The cancer death rates have been on the decline. Between 1991 through 2020, the rate dropped by 33%, thanks in large part to early detection and treatment advances. What hasn’t declined is the volume of prior authorizations required. If anything, volume is higher than ever as payers try to control costs through utilization management. As a result, says Oncology Insights, 70% of oncologists report needing full-time staff to manage prior… Read entire article here